Related Experiment Video
Updated: Dec 27, 2025
02:22
Full-Endoscopic Surgery for Hypothalamic Hamartoma Resection
Published on: April 12, 2024
779
Summary
Hyponatremia is common and harmful in cancer patients. Improved diagnostic testing and tailored treatments are crucial for better patient outcomes in oncology care.
Area of Science:
- Oncology
- Nephrology
- Internal Medicine
Background:
- Hyponatremia is a frequent complication in cancer patients.
- Cancer and its treatments uniquely influence hyponatremia development and management.
- Existing management strategies often fall short in this population.
Purpose of the Study:
- To highlight the challenges in managing hyponatremia in cancer patients.
- To emphasize the need for specific diagnostic and therapeutic guidelines.
- To improve patient outcomes by addressing this common electrolyte imbalance.
Main Methods:
- Review of current clinical practices and literature regarding hyponatremia in oncology.
- Analysis of the impact of cancer-specific factors on hyponatremia.
- Identification of gaps in diagnostic testing and treatment protocols.
Main Results:
- Appropriate diagnostic testing for hyponatremia is underutilized in cancer care.
- Hyponatremia is frequently observed in oncology patients despite its association with poor prognosis.
- Current treatment approaches may not adequately address the complexities of cancer-related hyponatremia.
Conclusions:
- There is a critical need for evidence-based guidance for managing hyponatremia in cancer patients.
- Optimizing diagnostic strategies and treatment protocols can enhance patient care and outcomes.
- Addressing hyponatremia is essential for improving the quality of life and survival in oncology patients.
Related Concept Videos
01:22Acute Kidney Injury VI: Nursing Management
302
Acute Kidney Injury (AKI) results in an inability to maintain fluid, electrolyte, and acid-base balance. Effective nursing management is critical in improving patient outcomes and includes comprehensive patient assessment and targeted interventions.Comprehensive Patient AssessmentA detailed history collection is essential, focusing on any recent infections, nephrotoxic medication use, or chronic conditions such as hypertension and diabetes that may contribute to AKI. During the physical...
302
01:11Renal Failure: Dose Adjustments
363
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
363
01:24Nephrotic Syndrome III : Nursing Management
233
Nursing management for nephrotic syndrome adapts as the disease progresses, with strategies evolving to address advancing symptoms and complications.Early-Stage Management In the early stages, nursing interventions for nephrotic syndrome resemble those used in managing acute glomerulonephritis, focusing on symptom monitoring, fluid balance, and managing mild to moderate edema.Vital Signs: Regularly monitor blood pressure, pulse, respiratory rate, and temperature to promptly identify...
233
01:27Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
534
5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...
534
01:25Regulation of Water Intake
2.5K
Osmolality refers to the number of solute particles per kilogram of solvent in a solution. Plasma osmolality specifically indicates the total number of solute particles per kilogram of water in blood plasma. This value reflects the body's hydration status and is tightly regulated through mechanisms controlling water intake and output. While water consumption is a conscious decision, the body has intrinsic regulatory systems to maintain fluid balance. Dehydration, a state of water deficit...
2.5K
01:25Hemodialysis III: Nursing Management
612
The nursing management of a patient undergoing hemodialysis includes several critical steps, starting with a thorough assessment before the procedure.Before the Hemodialysis ProcedureFirst, record the patient's vital signs—blood pressure, heart rate, respiratory rate, and temperature—to establish a baseline. This baseline is essential for detecting conditions such as hypotension that could impact the patient's response to dialysis. Document the patient's pre-dialysis weight, as this...
612